Novo Nordisk Research & Development US, Inc. H-1B wage filings
Plainsboro, NJ. Filings decided July 2025 to June 2026.
Novo Nordisk Research & Development US, Inc. filed 23 wage applications for H-1B and similar visas from July 2025 to June 2026. The median wage it offered was $135,000, 15.5% above the government's prevailing wage for the same jobs.
- Filings
- 23
- Positions covered
- 23
- Certified
- 100.0%
- Job titles
- 18
- Worksite cities
- 2
- Filings since FY2024
- 31
- Median offer change since FY2025
- +18%
Offered wage since 2024
Novo Nordisk Research & Development US, Inc.'s median H-1B wage offer rose 18%, from $134,680 in fiscal 2025 to $159,390 in fiscal 2026 so far. In fiscal 2026 it was 37.4% above the prevailing wage. Its busiest full year was fiscal 2025, with 25 filings.
Middle half of offered wagesMedian offered wageMedian prevailing wageFilings per year
Fiscal years run October to September. Fiscal 2026 is still running: these figures cover October 2025 to June 2026.
Novo Nordisk Research & Development US, Inc. by fiscal year
| Fiscal year | Filings | Median offered | vs year before | Median prevailing | vs prevailing |
|---|---|---|---|---|---|
| 2026 (Oct to Jun) | 5 | $159,390 | +18.3% | $127,858 | +37.4% |
| 2025 | 25 | $134,680 | n/a | $113,027 | +15.0% |
| 2024 | 1 | n/a | n/a | n/a | n/a |
Offered wage by job title
Middle half of offered wagesMedian offered wageMedian prevailing wage
| Job title | Filings | Median offered | Offered range and prevailing wage | vs prevailing |
|---|---|---|---|---|
| Associate Scientist I | 2 | $111,540 | +21.3% | |
| Assoc Scientist I, In Vitro Pharmacology | 2 | $113,916 | +38.0% | |
| Scientist I | 2 | $137,540 | +16.7% | |
| Senior Engineer I | 2 | $153,563 | +11.3% | |
| Senior Research Associate | 2 | $90,200 | +3.3% | |
| Assoc Computational Biologist | 1 | $109,200 | +18.7% | |
| Assoc Dir - Enterprise App | 1 | $209,684 | +1.0% | |
| Assoc Scientist I - in Vivo Pharmacology | 1 | $109,199 | +3.2% | |
| Assoc Scientist II - Discovery Research | 1 | $122,720 | +21.5% | |
| Associate Statistical Programming Director | 1 | $197,993 | +54.9% | |
| Data Scientist III | 1 | $135,000 | +18.3% | |
| Project Mgr - Research Proj MGMT | 1 | $150,800 | +11.7% | |
| Scientist I - Chem Dev | 1 | $130,000 | +15.0% | |
| Scientist I - GRT | 1 | $146,112 | +6.2% | |
| Scientist II - Rna Gene Therapy | 1 | $156,000 | +69.6% | |
| Senior Computational Biologist | 1 | $166,400 | +23.3% | |
| Senior Scientist I | 1 | $163,800 | +8.6% | |
| Sr Scientist I, BA Outsourcing | 1 | $185,400 | +37.4% | |
No job title on this page matches. Only the most-filed titles are listed.
Where the jobs are
| Worksite | Filings | Median offered |
|---|---|---|
| Lexington, MA | 22 | $137,700 |
| Boulder, CO | 1 | $130,000 |
By visa type: 23 H-1B. By outcome: 21 certified, 2 certified and later withdrawn.
Filings by quarter
Across all employers, filings bunch up in the first half of each year around the annual H-1B lottery, so compare a quarter with the same quarter a year earlier, not with the one before it.
Seniority of the jobs filed
The government assigns each job one of four wage levels. A higher level means a higher legal minimum.
What these numbers are
- They are wages Novo Nordisk Research & Development US, Inc. attested to on Labor Condition Applications (Form ETA-9035), not paychecks. Bonuses and stock are not included.
- A filing is not a visa or a hire. One filing can cover several positions, and some are later withdrawn. Wage figures use certified filings only.
- The prevailing wage is the minimum the employer must pay for that job in that area, set from government wage surveys.
Source: U.S. Department of Labor, OFLC disclosure data. How we clean and count it.